The contribution of mouse models to our understanding of systemic candidiasis

Edina K Szabo1, Donna M MacCallum

  • 1Aberdeen Fungal Group, School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, UK.

Insights

Systemic Candida infections in severely ill patients are life-threatening and difficult to diagnose. Mouse models are crucial for understanding fungal virulence and developing new antifungal treatments and diagnostics.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Candida species are commensals that can cause opportunistic infections, especially in severely ill patients.
  • Systemic Candida infections, particularly from Candida albicans, lead to high mortality rates (>40%) due to diagnostic challenges and delayed antifungal therapy.
  • Current diagnostic methods for systemic fungal infections are insufficient, mirroring bacterial infections.

Purpose of the Study:

  • To review the utility of mouse models in studying systemic Candida infections.
  • To highlight the contributions of these models to understanding fungal virulence and host responses.
  • To discuss the role of mouse models in developing novel antifungal therapies and diagnostics.

Main Methods:

  • Review of existing literature on systemic Candida infection mouse models.
  • Focus on two common models: intravenous infection and gastrointestinal colonization/dissemination.
  • Analysis of how these models inform research on fungal pathogenesis and treatment.

Main Results:

  • Mouse models effectively mimic human systemic Candida infections.
  • These models have advanced the understanding of Candida virulence factors.
  • Research using these models has contributed to the development of new antifungal strategies.

Conclusions:

  • Mouse models are essential tools for investigating systemic Candida infections.
  • Continued use of these models is vital for improving diagnostics and antifungal therapies.
  • Further research using these models can help reduce mortality associated with invasive fungal infections.